Pseudoephedrine 2006 Sales To Decline 35%, Perrigo Projects
This article was originally published in The Tan Sheet
Executive Summary
Perrigo's fiscal 2006 pseudoephedrine sales will decrease 35% to the $110 mil. to $120 mil. range, the company projected during a 2005 year-end and fourth quarter analysts call Sept. 7
You may also be interested in...
Perrigo’s Full Range Of Pseudoephedrine Stand-Ins Must Wait For Next Year
Perrigo will not have a complete phenylephrine portfolio available to replace pseudoephedrine products until next year's cough/cold season, the company said during a fiscal 2006 first-quarter earnings call
Perrigo’s Full Range Of Pseudoephedrine Stand-Ins Must Wait For Next Year
Perrigo will not have a complete phenylephrine portfolio available to replace pseudoephedrine products until next year's cough/cold season, the company said during a fiscal 2006 first-quarter earnings call
Perrigo’s Full Range Of Pseudoephedrine Stand-Ins Must Wait For Next Year
Perrigo will not have a complete phenylephrine portfolio available to replace pseudoephedrine products until next year's cough/cold season, the company said during a fiscal 2006 first-quarter earnings call